| Jun 2008 | 2007 | 2006 | 2005 | 2004 | |||
|---|---|---|---|---|---|---|---|
| Total Revenues ($Mil): | 232.45 | 182.91 | 152.73 | 130.69 | 83.49 | ||
| Depreciation & Amort ($Mil): | 4.81 | 4.81 | 4.71 | ||||
| Operating Income ($Mil): | 56.87 | 33.09 | 38.50 | N/C | N/C | ||
| Net Income ($Mil): | 46.97 | 22.93 | 22.79 | 15.78 | 11.47 | ||
| Earnings Per Share ($): | 1.57 | 0.77 | 0.93 | 0.69 | 0.56 | ||
| Dividends ($): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | |||
|---|---|---|---|---|---|---|---|
| Current Assets ($Mil): | 140.02 | 144.31 | 147.33 | ||||
| Current Liabilities ($Mil): | 52.37 | 55.66 | 64.34 | ||||
| Long Term Debt ($Mil): | 40.60 | 42.58 | 31.36 | ||||
| Shares Outstanding (000): | 29750 | 29750 | 27420 | 0 | 0 | 0 | 0 |
| Common Equity ($Mil): | 181.11 | 171.15 | 138.47 |
| Jun 2008 | 2007 | 2006 | 2005 | 2004 | |||
|---|---|---|---|---|---|---|---|
| Profit Margin (%): | 20.21 | 12.54 | 14.92 | 12.07 | 13.74 | 0.00 | 0.00 |
| Return on Equity (%): | 26.54 | 13.40 | 16.46 | 0.00 | 0.00 | 0.00 | 0.00 |
| Return on Assets (%): | 17 | 8.38 | 9.57 | 0.00 | 0.00 | 0.00 | 0.00 |
| P/E Ratio: | 12 | 13.45 | 7.32 | 7.45 | 8.25 | 0.00 | 0.00 |
| Price/Book: | 3 | 1.80 | 1.35 | NaN | NaN | NaN | NaN |
| Debt Equity: | 0.22 | 0.25 | 0.23 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage: | 641.00 | 515.00 | 34.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book Value ($): | 6.09 | 5.75 | 5.05 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price/Sales: | 1.39 | 2.38 | 1.22 | 0.89 | 1.13 | NaN | NaN |
| Dividend Payout (%): | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |

| AMGEN INC. | +9.10 | 56.09 | |
| GILEAD SCIENCES | -1.80 | 45.91 | |
| CELGENE CORPORA | -8.00 | 58.56 | |
| BIOGEN IDEC INC | -31.90 | 43.13 | |
| STEMCELLS INC. | -56.40 | 1.23 |
